Yanping Bai

Dr. Yanping Bai


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AWAo Wang
Ao Wang
YBYanping Bai
Yanping Bai

1 January 2016 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
YWYing Wang
Ying Wang
LWLili Wang
Lili Wang
HYHaoyu Yang
Haoyu Yang
WYWeichang Yuan
Weichang Yuan
JRJingyi Ren
Jingyi Ren
YBYanping Bai
Yanping Bai
Circulating T follicular helper (cTfh) cells are known to be involved in numerous immune-mediated diseases, but their pathological role in psoriasis is less fully investigated. Herein, we aimed to identify whether cTfh cells contributed to the pathogenesis of psoriasis. The frequency and function of cTfh cells were compared between patients with psoriasis vulgaris and healthy controls, and the infiltration of Tfh cells was detected between lesional and nonlesional skin tissues of psoriasis patients. Moreover, the dynamic change of cTfh cells before and after acitretin treatment was evaluated. Our results showed both increased frequency and activation (indicated by higher expression of ICOS, PD-1, HLA-DR, and Ki-67 and increased production of IL-21, IL-17, and IFN-γ) of cTfh cells in psoriasis patients. Compared with nonlesional skin tissues of psoriasis patients, the number of infiltrated Tfh cells was significantly increased in psoriasis lesions. In addition, positive correlations between the percentage of cTfh, functional markers on cTfh cells in peripheral blood and disease severity were noted. Furthermore, the frequency of cTfh cells and the levels of cytokines secreted by cTfh cells were all significantly decreased after 1-month treatment.

4 September 2020 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
ZHZehui He
Zehui He
GMGaetano Marrone
Gaetano Marrone
AOAihua Ou
Aihua Ou
HLHongxia Liu
Hongxia Liu
LMLin Ma
Lin Ma
CLChuanjian Lu
Chuanjian Lu
Background: Many previous studies have reported factors that contribute to health-related quality of life (HRQoL) for a single skin disease. However, little is known about generalized factors associated with HRQoL across skin diseases. The objective of this study was to investigate overall HRQoL, and to identify factors related to severely impaired HRQoL among patients with 16 different skin diseases. Methods: A cross-sectional study of 9845 patients with skin disease was conducted in 9 hospitals in China. HRQoL was assessed with the Chinese version of the Skindex-29 which measures dermatology-specific health along three domains (symptoms, emotions and functioning). With the published Skindex-29 cut-off scores for severely impaired HRQoL, logistic regression models assessed the relationship between severely impaired HRQoL and demographic/clinical characteristics, with adjustments for different skin diseases. To guarantee the models’ convergence, 16 skin diseases with frequencies of at least 100 were included, and the sample size was 8789. Results: Emotions was the most impaired aspect of HRQoL. Co-existing chronic diseases, 3 years or longer duration, and more severity were identified as associated factors for severely impaired HRQoL for each Skindex-29 domain, and for the aggregate. Being female, under 45 years old, and consuming alcohol were associated with a severely impaired emotion domain; Lack of exercise and smoking were associated with severely impaired symptoms and function domains, respectively. Conclusions: Skin diseases can affect many facets of HRQoL, but the emotional impairment deserves more attention. In addition to skin disease severity, this study shows that other chronic diseases and long duration are correlated with severely impaired HRQoL for patients with 16 clinical common skin diseases. This suggests the need for increased awareness in treating skin disease as a chronic disease. It also suggests that disease management decisions should consider HRQoL improvement, especially emotional conditions, when making management decisions.

7 March 2018 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
FWF. F. Wang
F. F. Wang
YWY. Wang
Y. Wang
LWL. Wang
L. Wang
TWT. S. Wang
T. S. Wang
YBYanping Bai
Yanping Bai

1 January 2021 in Immunology Letters
Verified
Journal Article
Closed access
WLWenjing Liu
Wenjing Liu
XZXuefeng Zhou
Xuefeng Zhou
AWAo Wang
Ao Wang
JMJie Ma
Jie Ma
YBYanping Bai
Yanping Bai

1 January 2017 in Immunology Letters
Verified
Journal Article
Closed access
YWYing Wang
Ying Wang
LWLili Wang
Lili Wang
YSYanchao Shi
Yanchao Shi
WFWang Fei Fei
Wang Fei Fei
HYHaoyu Yang
Haoyu Yang
YBYanping Bai
Yanping Bai